bioAffinity Technologies, Inc. Ratios

Ratios Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 90.28%31.26%36.09%
EBT Margin 631.28%-169,720.05%-312.58%-96.43%
EBIT Margin 220.27%-83,511.51%-314.84%-95.64%
EBITDA Margin 220.27%-83,299.52%-305.63%-93.90%
Operating Margin 220.27%-83,511.51%-314.84%-95.64%
Net Margin 631.47%-169,771.25%-313.41%-96.56%
FCF Margin 204.52%-89,336.50%-239.32%-78.44%
Efficiency
Inventory Average 0.01M0.02M
Assets Average 10.20M7.37M
Equity Average 7.95M3.73M
Invested Capital 11.30M6.06M3.44M
Asset Utilization Ratio 0.251.27
Leverage & Solvency
Interest Coverage Ratio -2.20-1.58-214.77-96.82
Debt to Equity 0.020.01
Debt Ratio 0.020.00
Equity Ratio 0.910.590.40
Times Interest Earned -2.20-1.58-214.77-96.82
Valuation
Enterprise Value 1.98M11.15M13.08M
Market Capitalization 13.39M13.97M14.18M
Return Ratios
Return on Sales 6.31%-3.13%-0.97%
Return on Capital Employed -1.00%-2.10%
Return on Assets -0.78%-1.23%
Return on Equity -1.00%-2.42%